Literature DB >> 23988219

Fetal cystic hygroma: the importance of natural history.

G Noia1, M Pellegrino, L Masini, D Visconti, C Manzoni, G Chiaradia, A Caruso.   

Abstract

OBJECTIVES: To evaluate the natural history of cystic hygroma (CH) in fetal and neonatal periods to enrich parental counselling. Ultrasonographic characteristics, associated syndromes, chromosomal anomalies, fetal cardiac pathology and life after birth were considered. STUDY
DESIGN: From May 1985 to September 2010, 207 pregnancies were seen the authors' centre with suspected vascular-lymphatic fetal malformation: 156 of them had CH. Cases were followed up by telephone interview to determine fetal and neonatal outcomes. Chi-squared test was used for statistical analysis.
RESULTS: Among the 156 cases of CH, the condition was septated in 75% of cases, associated with other pathologies in 74%, and retronuchal in 88%. Intrauterine regression was seen in 36% of cases, with complete disappearance in 77%. The karyotype was normal in 55% of cases. Follow-up was completed in 85 cases and revealed 54 spontaneous abortions (63%) and 31 live births (37%). Amongst these, 21 out of 31 children had a favourable outcome (68%). A negative embryo-fetal outcome was significantly associated with CH being associated with other pathologies, such as hydrops, retronuchal position and altered karyotype. Spontaneous regression or resolution of CH was associated with live births.
CONCLUSIONS: The management of pregnancies with a diagnosis of fetal CH requires knowledge of natural history of the malformation for appropriate parental counselling.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Chromosomal abnormality; Congenital cardiac anomaly; Fetal cystic hygroma; Natural history; Prenatal diagnosis

Mesh:

Year:  2013        PMID: 23988219     DOI: 10.1016/j.ejogrb.2013.07.043

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  8 in total

1.  Prognostic value of a simplified anatomically based nomenclature for fetal nuchal lymphatic anomalies.

Authors:  Beck Longstreet; Karthik Balakrishnan; Babette Saltzman; Jonathan A Perkins; Manjiri Dighe
Journal:  Otolaryngol Head Neck Surg       Date:  2014-11-19       Impact factor: 3.497

2.  Management and outcomes of cystic hygromas: experience of a tertiary center.

Authors:  Gokcen Orgul; Ozgur Ozyuncu; Ahmet Oktem; M Sinan Beksac
Journal:  J Ultrasound       Date:  2017-05-04

Review 3.  Prenatal Ultrasound Evaluation and Outcome of Pregnancy with Fetal Cystic Hygromas and Lymphangiomas.

Authors:  Yen-Ni Chen; Chih-Ping Chen; Chen-Ju Lin; Shin-Wen Chen
Journal:  J Med Ultrasound       Date:  2017-04-17

Review 4.  Perinatal post-mortem ultrasound (PMUS): radiological-pathological correlation.

Authors:  Susan C Shelmerdine; Neil J Sebire; Owen J Arthurs
Journal:  Insights Imaging       Date:  2019-08-21

5.  [Prognosis of fetuses with cystichygroma and nuchal translucency/nuchal fold thickening on prenatal echography].

Authors:  Yayun Wang; Yuan Chen; Mengmeng Yang; Fangfang Xi; Qitao Zhan; Ying Jiang; Baihui Zhao; Qiong Luo
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2019-06-25

6.  Treatment of cystic hygroma in a young infant through multidisciplinary approach involving sirolimus, sclerotherapy, and debulking surgery.

Authors:  Haya Azouz; Haneen Salah; Saad Al-Ajlan; Mohammad Badran
Journal:  JAAD Case Rep       Date:  2016-08-25

7.  Genetic Burden and Outcome of Cystic Hygromas Detected Antenatally: Results of 93 Pregnancies from a Single Center in the Northern Region of Turkey.

Authors:  Huri Sema Aymelek; Gönül Oğur; Miğraci Tosun; Ümmet Abur; Engin Altundağ; Handan Çelik; Emel Kurtoğlu; Erdal Malatyalıoğlu; Ömer Salih Akar; Tayfun Alper
Journal:  J Med Ultrasound       Date:  2019-04-10

8.  Ultrasonographic diagnosis, classification, and treatment of cervical lymphatic malformation in paediatric patients: a retrospective study.

Authors:  Jiaoling Li; Wei Zhong; Xiuping Geng; Xiaofang Liu; Xiangxiang Zhang; Yurun Wang; Haibo Li
Journal:  BMC Pediatr       Date:  2020-09-19       Impact factor: 2.125

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.